Juno Therapeutics Signs $1 Billion Development Pact With Celgene

By: via Benzinga
Juno Therapeutics Inc (NASDAQ: JUNO) soared Monday afternoon on news that it signed a 10-year drug development pact with Celgene ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.